Advaxis, Inc. Logo

Advaxis, Inc.

ADXS

(0.2)
Stock Price

0,02 USD

-412.61% ROA

-404.18% ROE

-0.1x PER

Market Cap.

6.130.676,00 USD

-55.76% DER

0% Yield

-10784.41% NPM

Advaxis, Inc. Stock Analysis

Advaxis, Inc. Fundamental Analysis

Fundamental analysis in stock investing is like studying the foundation of a house before buying it. It involves looking at a company's financial health, like its earnings, assets, and debts, to determine if it's a good investment based on its fundamental strength and potential for growth.

Advaxis, Inc. Fundamental Stock Analysis
# Analysis Rating
1 Graham Number

The Graham number analysis indicates that this company's stock price is likely undervalued, raising prospects for a favorable investment opportunity.

2 ROE

Negative ROE (-177%) indicates poor financial performance, raising concerns about profitability and efficiency in utilizing shareholders' equity.

3 ROA

The stock's ROA (-229.8%) indicates that it's not effectively utilizing its assets to generate profits, making it a less favorable option to invest and earn consistent returns.

4 PBV

The stock's high Price-to-Book Value (P/BV) ratio (3.98x) suggests it's overvalued, potentially making it an expensive investment.

5 DER

The company has a high debt to equity ratio (153%), which means it owes a lot of money compared to what it actually owns, making it financially risky.

6 Revenue Growth

Company's revenue has remained stagnant over the past three years, indicating a lack of growth and making it a less favorable option.

7 Net Profit Growth

Despite the passage of five years, this company's net profit has not shown any improvement, highlighting a lack of growth and making it a less appealing investment prospect.

8 Assets Growth

Regrettably, this company's revenue has shown no signs of growth over the past three years, suggesting limited potential for returns and making it a less appealing choice.

9 Dividend Growth

Investors should note the company's stagnant dividend growth over the past three years, indicating limited profitability and potentially diminishing returns.

10 Dividend

The company's lack of dividends in the past three years may concern investors seeking regular income.

11 Buffet Intrinsic Value

Based on Warren Buffett's formula, the company's stock seems overpriced (-2), indicating a potential drawback for investors as its market price exceeds its estimated intrinsic value.

Advaxis, Inc. Technical Analysis

Technical analysis in stock investing is like reading the patterns on a weather map to predict future weather conditions. It involves studying past stock price movements and trading volumes to make predictions about where a stock's price might go next, without necessarily looking at the company's financial health.

Advaxis, Inc. Technical Stock Analysis
# Analysis Recommendation
1 Awesome Oscillator Buy
2 MACD Sell
3 RSI Hold
4 Stoch RSI Sell

Advaxis, Inc. Price Chart

Financial Statements

Financial statements are like report cards for companies. They show how much money a company makes (income statement), what it owns and owes (balance sheet), and where it spends its money (cash flow statement), helping stock investors understand if a company is healthy and worth investing in.

Income Statements

An income statement for a company is like a scoreboard for its profits and losses. It shows how much money the company made (revenue) and how much it spent to make that money (expenses), helping stock investors see if a company is making a profit or not.

Revenue in stock investing is the total amount of money a company earns from its sales, and it's a key factor that investors consider to assess a company's financial performance and growth potential.

Advaxis, Inc. Revenue
Year Revenue Growth
2002 0
2003 0 0%
2004 116.406 100%
2005 552.868 78.95%
2006 431.961 -27.99%
2007 154.201 -180.13%
2008 65.736 -134.58%
2009 29.690 -121.41%
2010 508.481 94.16%
2011 0 0%
2012 0 0%
2013 0 0%
2014 1.000.000 100%
2015 0 0%
2016 3.994.856 100%
2017 12.031.050 66.8%
2018 6.063.000 -98.43%
2019 2.334.000 -159.77%
2020 253.000 -822.53%
2021 3.240.000 92.19%
2022 250.000 -1196%
2023 0 0%

Research and Development Expenses are the costs a company incurs to create and improve its products or services, which can be important for investors to evaluate a company's innovation and potential for future growth.

Advaxis, Inc. Research and Development Expenses
Year Research and Development Expenses Growth
2002 0
2003 0 0%
2004 125.942 100%
2005 1.175.536 89.29%
2006 1.404.164 16.28%
2007 2.128.096 34.02%
2008 2.481.840 14.25%
2009 2.315.557 -7.18%
2010 4.904.298 52.79%
2011 8.078.901 39.29%
2012 6.646.094 -21.56%
2013 5.621.989 -18.22%
2014 8.687.168 35.28%
2015 24.220.610 64.13%
2016 48.774.589 50.34%
2017 71.900.462 32.16%
2018 56.970.000 -26.21%
2019 14.424.000 -294.97%
2020 15.612.000 7.61%
2021 10.562.000 -47.81%
2022 7.616.000 -38.68%
2023 22.732.000 66.5%

General and Administrative Expenses are the costs a company incurs to run its day-to-day operations, such as office rent, salaries, and utilities, which investors consider to understand a company's overall efficiency and management effectiveness.

Advaxis, Inc. General and Administrative Expenses
Year General and Administrative Expenses Growth
2002 10.000
2003 10.000 0%
2004 524.368 98.09%
2005 1.219.792 57.01%
2006 2.077.062 41.27%
2007 2.629.094 21%
2008 3.035.680 13.39%
2009 2.701.133 -12.39%
2010 3.530.198 23.48%
2011 4.939.935 28.54%
2012 5.688.677 13.16%
2013 9.071.613 37.29%
2014 11.851.410 23.46%
2015 24.450.047 51.53%
2016 31.712.505 22.9%
2017 38.658.464 17.97%
2018 19.472.000 -98.53%
2019 4.336.000 -349.08%
2020 11.090.000 60.9%
2021 11.464.000 3.26%
2022 8.891.000 -28.94%
2023 5.792.000 -53.5%

EBITDA stands for Earnings Before Interest, Taxes, Depreciation, and Amortization. It is a measure that helps stock investors analyze a company's profitability by looking at its earnings without considering certain expenses. This helps to get a clearer picture of the company's financial performance and its ability to generate cash flow.

Advaxis, Inc. EBITDA
Year EBITDA Growth
2002 -10.000
2003 -10.000 0%
2004 -518.143 98.07%
2005 -1.801.359 71.24%
2006 -193.696 -829.99%
2007 -7.094.942 97.27%
2008 -5.301.068 -33.84%
2009 -4.875.844 -8.72%
2010 -7.787.067 37.39%
2011 -13.781.332 43.5%
2012 -12.172.993 -13.21%
2013 -18.041.169 32.53%
2014 -19.292.733 6.49%
2015 -48.356.317 60.1%
2016 -76.025.101 36.39%
2017 -97.427.612 21.97%
2018 -72.278.000 -34.8%
2019 -17.561.000 -311.58%
2020 -24.394.000 28.01%
2021 -18.766.000 -29.99%
2022 -19.310.000 2.82%
2023 -28.348.000 31.88%

Gross profit is the money a company makes from selling its products or services after subtracting the cost of producing or providing them, and it is an important measure for investors to understand a company's profitability.

Advaxis, Inc. Gross Profit
Year Gross Profit Growth
2002 0
2003 0 0%
2004 116.406 100%
2005 552.868 78.95%
2006 431.961 -27.99%
2007 154.201 -180.13%
2008 65.736 -134.58%
2009 29.690 -121.41%
2010 508.481 94.16%
2011 0 0%
2012 0 0%
2013 0 0%
2014 1.000.000 100%
2015 0 0%
2016 3.994.856 100%
2017 12.031.050 66.8%
2018 6.063.000 -98.43%
2019 1.049.000 -477.98%
2020 -1.032.000 201.65%
2021 -468.000 -120.51%
2022 250.000 287.2%
2023 -28.524.000 100.88%

Net income in stock investing is like the money a company actually gets to keep as profit after paying all its bills, and it's an important measure to understand how well a company is doing financially.

Advaxis, Inc. Net Profit
Year Net Profit Growth
2002 -10.000
2003 -10.000 0%
2004 -538.076 98.14%
2005 -1.805.789 70.2%
2006 -6.197.744 70.86%
2007 -2.454.453 -152.51%
2008 -5.416.418 54.68%
2009 929.244 682.88%
2010 -10.812.200 108.59%
2011 -8.115.740 -33.23%
2012 -12.069.687 32.76%
2013 -19.986.826 39.61%
2014 -16.525.314 -20.95%
2015 -47.031.118 64.86%
2016 -73.556.230 36.06%
2017 -93.435.402 21.28%
2018 -66.515.000 -40.47%
2019 -17.792.000 -273.85%
2020 -26.469.000 32.78%
2021 -17.862.000 -48.19%
2022 -14.359.000 -24.4%
2023 -29.356.000 51.09%

EPS, or earnings per share, is a measure that shows how much profit a company has earned for each outstanding share of its stock, and it is important for stock investors as it helps understand the profitability of a company and compare it with other companies in the market.

Advaxis, Inc. Earning per Share (EPS)
Year Earning per Share (EPS) Growth
2002 0
2003 0 0%
2004 -721 100%
2005 -95 -667.02%
2006 -301 68.67%
2007 -99 -206.12%
2008 -7.261 98.65%
2009 1.207 701.99%
2010 -10.748 111.22%
2011 -5.461 -96.8%
2012 -5.648 3.29%
2013 -4.786 -17.99%
2014 -1.159 -312.94%
2015 -2.014 42.42%
2016 -2.493 19.25%
2017 -2.767 9.87%
2018 -1.549 -78.57%
2019 -2 -77350%
2020 -35 94.12%
2021 -11 -209.09%
2022 0 0%
2023 -6 100%

Cashflow Statements

Cashflow statements show the movement of money in and out of a company, helping stock investors understand how much money a company makes and spends. By examining cashflow statements, investors can assess if a company is generating enough cash to pay its bills, invest in growth, and provide returns to stockholders.

Free cash flow is the leftover cash that a company generates after covering its operating expenses and capital expenditures, which is important for stock investors as it shows how much money a company has available to invest in growth, pay dividends, or reduce debt.

Advaxis, Inc. Free Cashflow
Year Free Cashflow Growth
2002 -10.000
2003 -10.000 0%
2004 -436.636 97.71%
2005 -1.620.507 73.06%
2006 -2.054.040 21.11%
2007 -4.630.014 55.64%
2008 -4.364.400 -6.09%
2009 -2.343.385 -86.24%
2010 -7.291.149 67.86%
2011 -9.239.200 21.08%
2012 -4.965.093 -86.08%
2013 -9.012.694 44.91%
2014 -17.461.334 48.38%
2015 -25.930.328 32.66%
2016 -13.519.729 -91.8%
2017 -81.546.170 83.42%
2018 -64.970.000 -25.51%
2019 -16.280.000 -299.08%
2020 -22.688.000 28.24%
2021 -15.899.000 -42.7%
2022 -15.284.000 -4.02%
2023 -6.981.000 -118.94%

Operating cash flow represents the cash generated or consumed by a company's day-to-day operations, excluding external investing or financing activities, and is crucial for stock investors as it shows how much cash a company is generating from its core business operations.

Advaxis, Inc. Operating Cashflow
Year Operating Cashflow Growth
2002 -10.000
2003 -10.000 0%
2004 -436.636 97.71%
2005 -1.539.930 71.65%
2006 -1.795.045 14.21%
2007 -4.234.046 57.6%
2008 -4.153.088 -1.95%
2009 -2.034.636 -104.12%
2010 -6.423.940 68.33%
2011 -8.942.842 28.17%
2012 -4.568.344 -95.76%
2013 -8.713.945 47.57%
2014 -17.021.659 48.81%
2015 -24.135.544 29.47%
2016 -9.070.545 -166.09%
2017 -76.923.985 88.21%
2018 -62.129.000 -23.81%
2019 -14.950.000 -315.58%
2020 -21.940.000 31.86%
2021 -15.439.000 -42.11%
2022 -15.284.000 -1.01%
2023 -6.981.000 -118.94%

Capex, short for capital expenditures, refers to the money a company spends on acquiring or upgrading tangible assets like buildings, equipment, or technology, which is important for stock investors as it indicates how much a company is investing in its infrastructure to support future growth and profitability.

Advaxis, Inc. Capital Expenditure
Year Capital Expenditure Growth
2002 0
2003 0 0%
2004 0 0%
2005 80.577 100%
2006 258.995 68.89%
2007 395.968 34.59%
2008 211.312 -87.39%
2009 308.749 31.56%
2010 867.209 64.4%
2011 296.358 -192.62%
2012 396.749 25.3%
2013 298.749 -32.8%
2014 439.675 32.05%
2015 1.794.784 75.5%
2016 4.449.184 59.66%
2017 4.622.185 3.74%
2018 2.841.000 -62.7%
2019 1.330.000 -113.61%
2020 748.000 -77.81%
2021 460.000 -62.61%
2022 0 0%
2023 0 0%

Balance Sheet

Balance sheets provide a snapshot of a company's financial health and its assets (such as cash, inventory, and property) and liabilities (like debts and obligations) at a specific point in time. For stock investors, balance sheets help assess the company's overall worth and evaluate its ability to meet financial obligations and support future growth.

Equity refers to the ownership interest or stake that shareholders have in a company, representing their claim on its assets and earnings after all debts and liabilities are paid.

Advaxis, Inc. Equity
Year Equity Growth
2002 0
2003 0 0%
2004 -1.339.496 100%
2005 1.751.575 176.47%
2006 -3.707.141 147.25%
2007 4.267.979 186.86%
2008 -839.311 608.51%
2009 -15.733.328 94.67%
2010 -14.802.631 -6.29%
2011 -12.279.713 -20.55%
2012 -5.962.724 -105.94%
2013 18.002.142 133.12%
2014 20.629.986 12.74%
2015 115.598.875 82.15%
2016 119.302.194 3.1%
2017 54.260.167 -119.87%
2018 24.051.000 -125.6%
2019 14.453.000 -66.41%
2020 30.180.000 52.11%
2021 38.888.000 22.39%
2022 23.627.000 -64.59%
2023 -6.241.000 478.58%

Assets represent the valuable resources that a company owns, such as cash, inventory, property, and equipment, and understanding a company's assets helps investors assess its value and potential for generating future profits.

Advaxis, Inc. Assets
Year Assets Growth
2002 0
2003 0 0%
2004 502.083 100%
2005 2.904.039 82.71%
2006 4.002.704 27.45%
2007 5.460.354 26.7%
2008 1.331.020 -310.24%
2009 2.714.317 50.96%
2010 2.875.186 5.6%
2011 5.640.562 49.03%
2012 3.815.797 -47.82%
2013 23.585.921 83.82%
2014 23.377.813 -0.89%
2015 119.605.693 80.45%
2016 169.044.060 29.25%
2017 93.641.778 -80.52%
2018 62.267.000 -50.39%
2019 20.054.000 -210.5%
2020 38.526.000 47.95%
2021 46.780.000 17.64%
2022 25.930.000 -80.41%
2023 6.981.000 -271.44%

Liabilities refer to the financial obligations or debts that a company owes to creditors or external parties, and understanding a company's liabilities is important for investors as it helps assess the company's financial risk and ability to meet its obligations.

Advaxis, Inc. Liabilities
Year Liabilities Growth
2002 0
2003 100.000 100%
2004 1.841.579 94.57%
2005 1.152.464 -59.79%
2006 7.709.845 85.05%
2007 1.192.375 -546.6%
2008 2.170.331 45.06%
2009 18.447.645 88.24%
2010 17.677.817 -4.35%
2011 17.920.275 1.35%
2012 9.778.521 -83.26%
2013 5.583.779 -75.12%
2014 2.747.827 -103.21%
2015 4.006.818 31.42%
2016 49.741.866 91.94%
2017 39.381.611 -26.31%
2018 38.216.000 -3.05%
2019 5.601.000 -582.31%
2020 8.346.000 32.89%
2021 7.892.000 -5.75%
2022 2.303.000 -242.68%
2023 13.222.000 82.58%

Advaxis, Inc. Financial Ratio (TTM)

Valuation Metrics

Revenue per Share
0.05
Net Income per Share
-5.93
Price to Earning Ratio
-0.1x
Price To Sales Ratio
23.31x
POCF Ratio
-0.16
PFCF Ratio
-0.37
Price to Book Ratio
-0.44
EV to Sales
28.47
EV Over EBITDA
-0.23
EV to Operating CashFlow
-0.45
EV to FreeCashFlow
-0.45
Earnings Yield
-10.4
FreeCashFlow Yield
-2.69
Market Cap
0,01 Bil.
Enterprise Value
0,01 Bil.
Graham Number
13.19
Graham NetNet
-2.32

Income Statement Metrics

Net Income per Share
-5.93
Income Quality
0.87
ROE
-4.04
Return On Assets
-4.06
Return On Capital Employed
20.92
Net Income per EBT
0.89
EBT Per Ebit
0.99
Ebit per Revenue
-122.96
Effective Tax Rate
0.11

Margins

Sales, General, & Administrative to Revenue
43.25
Research & Developement to Revenue
79.53
Stock Based Compensation to Revenue
4.94
Gross Profit Margin
-26.51
Operating Profit Margin
-122.96
Pretax Profit Margin
-121.69
Net Profit Margin
-107.84

Dividends

Dividend Yield
0
Dividend Yield %
0
Payout Ratio
0
Dividend Per Share
0

Operating Metrics

Operating Cashflow per Share
-3.49
Free CashFlow per Share
-3.45
Capex to Operating CashFlow
-0.01
Capex to Revenue
0.76
Capex to Depreciation
1.6
Return on Invested Capital
21.24
Return on Tangible Assets
-4.13
Days Sales Outstanding
0
Days Payables Outstanding
255.07
Days of Inventory on Hand
0
Receivables Turnover
0
Payables Turnover
1.43
Inventory Turnover
0
Capex per Share
0.04

Balance Sheet

Cash per Share
0,44
Book Value per Share
-1,30
Tangible Book Value per Share
-1.33
Shareholders Equity per Share
-1.3
Interest Debt per Share
1.59
Debt to Equity
-0.56
Debt to Assets
0.5
Net Debt to EBITDA
-0.04
Current Ratio
0.53
Tangible Asset Value
-0,01 Bil.
Net Current Asset Value
-0,01 Bil.
Invested Capital
-0.56
Working Capital
0,00 Bil.
Intangibles to Total Assets
0.02
Average Receivables
0,00 Bil.
Average Payables
0,00 Bil.
Average Inventory
0
Debt to Market Cap
0.57

Dividends

Dividends in stock investing are like rewards that companies give to their shareholders. They are a portion of the company's profits distributed to investors, typically in the form of cash payments, as a way for them to share in the company's success.

Advaxis, Inc. Dividends
Year Dividends Growth

Advaxis, Inc. Profile

About Advaxis, Inc.

Advaxis, Inc., a clinical-stage biotechnology company, focuses on the discovery, development, and commercialization of proprietary Listeria monocytogenes (Lm) technology antigen delivery products in the United States. The company is developing ADXS-PSA, which is in Phase 2 clinical trials for the treatment of metastatic prostate cancer; ADXS-503 that is in Phase 1/2 clinical trials for the treatment of non-small cell lung cancer; and ADXS-504 for the treatment of prostate cancer. It is also conducting clinical studies of Lm Technology immunotherapies in the following areas of disease focused hotspot/off-the-shelf neoantigen-directed therapies; human papilloma virus-associated cancers; and prostate cancer. The company has collaborations and partnerships with Merck & Co., Inc.; OS Therapies, LLC; Aratana Therapeutics Inc.; Biocon Limited; Global BioPharma Inc.; Knight Therapeutics Inc; and others. Advaxis, Inc. was founded in 2002 and is based in Monmouth Junction, New Jersey.

CEO
Dr. Ruth Ben Yakar Ph.D.
Employee
14
Address
9 Deer Park Drive
Monmouth Junction, 08852

Advaxis, Inc. Executives & BODs

Advaxis, Inc. Executives & BODs
# Name Age
1 Dr. Stela Gangrenovitch Ph.D.
Co-Founder, Chief Scientist Officer and Director
70
2 Mr. Mark Gengrinovitch LLB
Co-Founder, Chief Financial Officer and Director
70
3 Dr. Ruth Ben Yakar Ph.D.
Chief Executive Officer
70

Advaxis, Inc. Competitors